Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2015

Open Access 01-12-2015 | Research article

Role of enteral nutrition in nonthyroidal illness syndrome: a retrospective observational study

Authors: Ranran Li, Jianan Ren, Qin Wu, Gefei Wang, Xiuwen Wu, Jun Chen, Guanwei Li, Zhiwu Hong, Huajian Ren, Yunzhao Zhao, Jieshou Li

Published in: BMC Endocrine Disorders | Issue 1/2015

Login to get access

Abstract

Background

The nonthyroidal illness syndrome (NTIS) is prevalent among patients with enterocutaneous fistula and is associated with poor outcomes. The present study aimed to explore the role of enteral nutrition (EN) therapy on thyroid function among patients with enterocutaneous fistula and NTIS.

Methods

We conducted a retrospective observational study among patients with enterocutaneous fistula between January 2013 and April 2014. All enrolled patients received EN therapy. Thyroid function and other parameters were measured.

Results

After administration of 4 weeks of EN therapy, NTIS was resolved in 66 patients (Group A), while it persisted in 14 patients (Group B). The overall treatment success rate was 82.50 %. There were no significant differences between groups A and B at baseline for all parameters, except for the time from admission to start of EN therapy. The logistic analysis revealed that the time from admission to start of EN therapy was a significant independent indicator for achieving resolution of NTIS in our cohort.

Conclusions

This retrospective observational cohort study demonstrated that EN therapy can aid in the resolution of NTIS among patients with enterocutaneous fistula. These findings confirm the benefit of EN in the treatment of enterocutaneous fistula.
Appendix
Available only for authorised users
Literature
1.
go back to reference Han G, Ren J, Liu S, Gu G, Ren H, Yan D, et al. Nonthyroidal illness syndrome in enterocutaneous fistulas. Am J Surg. 2013;206(3):386–92. Han G, Ren J, Liu S, Gu G, Ren H, Yan D, et al. Nonthyroidal illness syndrome in enterocutaneous fistulas. Am J Surg. 2013;206(3):386–92.
2.
go back to reference Adler SM, Wartofsky L. The nonthyroidal illness syndrome. Endocrinol Metab Clin North Am. 2007;36(3):657–72. vi.CrossRefPubMed Adler SM, Wartofsky L. The nonthyroidal illness syndrome. Endocrinol Metab Clin North Am. 2007;36(3):657–72. vi.CrossRefPubMed
3.
go back to reference Meyer S, Schuetz P, Wieland M, Nusbaumer C, Mueller B, Christ-Crain M. Low triiodothyronine syndrome: a prognostic marker for outcome in sepsis? Endocrine. 2011;39(2):167–74.CrossRefPubMed Meyer S, Schuetz P, Wieland M, Nusbaumer C, Mueller B, Christ-Crain M. Low triiodothyronine syndrome: a prognostic marker for outcome in sepsis? Endocrine. 2011;39(2):167–74.CrossRefPubMed
4.
go back to reference Brent GA, Hershman JM. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab. 1986;63(1):1–8.CrossRefPubMed Brent GA, Hershman JM. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab. 1986;63(1):1–8.CrossRefPubMed
5.
go back to reference Acker CG, Singh AR, Flick RP, Bernardini J, Greenberg A, Johnson JP. A trial of thyroxine in acute renal failure. Kidney Int. 2000;57(1):293–8.CrossRefPubMed Acker CG, Singh AR, Flick RP, Bernardini J, Greenberg A, Johnson JP. A trial of thyroxine in acute renal failure. Kidney Int. 2000;57(1):293–8.CrossRefPubMed
6.
go back to reference Acker CG, Flick R, Shapiro R, Scantlebury VP, Jordan ML, Vivas C, et al. Thyroid hormone in the treatment of post‐transplant Acute Tubular Necrosis (ATN). Am J Transplant. 2002;2(1):57–61. Acker CG, Flick R, Shapiro R, Scantlebury VP, Jordan ML, Vivas C, et al. Thyroid hormone in the treatment of post‐transplant Acute Tubular Necrosis (ATN). Am J Transplant. 2002;2(1):57–61.
7.
go back to reference DuncanPerez-Guisado J, de Haro-Padilla JM, Rioja LF, Derosier LC, de la Torre JI. The potential association of later initiation of oral/enteral nutrition on euthyroid sick syndrome in burn patients. Int J Endocrinol. 2013;2013:707360. DuncanPerez-Guisado J, de Haro-Padilla JM, Rioja LF, Derosier LC, de la Torre JI. The potential association of later initiation of oral/enteral nutrition on euthyroid sick syndrome in burn patients. Int J Endocrinol. 2013;2013:707360.
8.
go back to reference DeBiasse M, Wilmore D. What is optimal nutritional support? New Horiz. 1994;2(2):122.PubMed DeBiasse M, Wilmore D. What is optimal nutritional support? New Horiz. 1994;2(2):122.PubMed
9.
go back to reference Michalaki M, Vagenakis AG, Makri M, Kalfarentzos F, Kyriazopoulou V. Dissociation of the early decline in serum T3 concentration and serum IL-6 rise and TNFα in nonthyroidal illness syndrome induced by abdominal surgery. J Clin Endocrinol Metab. 2001;86(9):4198–205.PubMed Michalaki M, Vagenakis AG, Makri M, Kalfarentzos F, Kyriazopoulou V. Dissociation of the early decline in serum T3 concentration and serum IL-6 rise and TNFα in nonthyroidal illness syndrome induced by abdominal surgery. J Clin Endocrinol Metab. 2001;86(9):4198–205.PubMed
10.
go back to reference Koenig RJ. Modeling the nonthyroidal illness syndrome. Curr Opin Endocrinol Diabetes Obes. 2008;15(5):466–9.CrossRefPubMed Koenig RJ. Modeling the nonthyroidal illness syndrome. Curr Opin Endocrinol Diabetes Obes. 2008;15(5):466–9.CrossRefPubMed
11.
go back to reference Yuan Y, Ren J, Gu G, Chen J, Li J. Early enteral nutrition improves outcomes of open abdomen in gastrointestinal fistula patients complicated with severe sepsis. Nutr Clin Pract. 2011;26(6):688–94.CrossRefPubMed Yuan Y, Ren J, Gu G, Chen J, Li J. Early enteral nutrition improves outcomes of open abdomen in gastrointestinal fistula patients complicated with severe sepsis. Nutr Clin Pract. 2011;26(6):688–94.CrossRefPubMed
12.
go back to reference Pappa TA, Vagenakis AG, Alevizaki M. The nonthyroidal illness syndrome in the non-critically ill patient. Eur J Clin Invest. 2011;41(2):212–20.CrossRefPubMed Pappa TA, Vagenakis AG, Alevizaki M. The nonthyroidal illness syndrome in the non-critically ill patient. Eur J Clin Invest. 2011;41(2):212–20.CrossRefPubMed
13.
go back to reference Chopra IJ. Euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metab. 1997;82(2):329–34.CrossRefPubMed Chopra IJ. Euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metab. 1997;82(2):329–34.CrossRefPubMed
14.
go back to reference Bello G. Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU. CHEST J. 2009;135(6):1448.CrossRef Bello G. Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU. CHEST J. 2009;135(6):1448.CrossRef
15.
go back to reference Rothwell PM, Lawler PG. Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med. 1995;23(1):78–83.CrossRefPubMed Rothwell PM, Lawler PG. Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med. 1995;23(1):78–83.CrossRefPubMed
16.
go back to reference LoPresti JS, Eigen A, Kaptein E, Anderson KP, Spencer CA, Nicoloff JT. Alterations in 3, 3'5'-triiodothyronine metabolism in response to propylthiouracil, dexamethasone, and thyroxine administration in man. J Clin Invest. 1989;84(5):1650. LoPresti JS, Eigen A, Kaptein E, Anderson KP, Spencer CA, Nicoloff JT. Alterations in 3, 3'5'-triiodothyronine metabolism in response to propylthiouracil, dexamethasone, and thyroxine administration in man. J Clin Invest. 1989;84(5):1650.
17.
go back to reference Kakucska I, Romero L, Clark B, Rondeel J, Qi Y, Alex S, et al. Suppression of thyrotropin-releasing hormone gene expression by interleukin-1-beta in the rat: implications for nonthyroidal illness. Neuroendocrinology. 1994;59(2):129–37. Kakucska I, Romero L, Clark B, Rondeel J, Qi Y, Alex S, et al. Suppression of thyrotropin-releasing hormone gene expression by interleukin-1-beta in the rat: implications for nonthyroidal illness. Neuroendocrinology. 1994;59(2):129–37.
18.
go back to reference Girvent M, Maestro S, Hernández R, Carajol I, Monné J, Sancho JJ, et al. Euthyroid sick syndrome, associated endocrine abnormalities, and outcome in elderly patients undergoing emergency operation. Surgery. 1998;123(5):560–7. Girvent M, Maestro S, Hernández R, Carajol I, Monné J, Sancho JJ, et al. Euthyroid sick syndrome, associated endocrine abnormalities, and outcome in elderly patients undergoing emergency operation. Surgery. 1998;123(5):560–7.
19.
go back to reference Douyon L, Schteingart DE. Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion. Endocrinol Metab Clin N Am. 2002;31(1):173–89.CrossRef Douyon L, Schteingart DE. Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion. Endocrinol Metab Clin N Am. 2002;31(1):173–89.CrossRef
20.
go back to reference Albero R, Sanz A, Playán J. Fasting metabolism. Endocrinol Nutr. 2004;51:139–48.CrossRef Albero R, Sanz A, Playán J. Fasting metabolism. Endocrinol Nutr. 2004;51:139–48.CrossRef
21.
go back to reference Hama S, Kitaoka T, Shigenobu M, Watanabe A, Imura I, Seno H, et al. Malnutrition and nonthyroidal illness syndrome after stroke. Metabolism. 2005;54(6):699–704. Hama S, Kitaoka T, Shigenobu M, Watanabe A, Imura I, Seno H, et al. Malnutrition and nonthyroidal illness syndrome after stroke. Metabolism. 2005;54(6):699–704.
22.
go back to reference Khorasani EN, Mansouri F. Effect of early enteral nutrition on morbidity and mortality in children with burns. Burns. 2010;36(7):1067–71.CrossRefPubMed Khorasani EN, Mansouri F. Effect of early enteral nutrition on morbidity and mortality in children with burns. Burns. 2010;36(7):1067–71.CrossRefPubMed
Metadata
Title
Role of enteral nutrition in nonthyroidal illness syndrome: a retrospective observational study
Authors
Ranran Li
Jianan Ren
Qin Wu
Gefei Wang
Xiuwen Wu
Jun Chen
Guanwei Li
Zhiwu Hong
Huajian Ren
Yunzhao Zhao
Jieshou Li
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2015
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-015-0061-y

Other articles of this Issue 1/2015

BMC Endocrine Disorders 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.